Growth Metrics

MeiraGTx Holdings (MGTX) Receivables - Other (2019 - 2025)

MeiraGTx Holdings posted quarterly Receivables - Other of $270000.0 for Q1 2025, down 71.58% on a QoQ basis from $950000.0 in Q4 2024.

MeiraGTx Holdings (MGTX) has 7 years of Receivables - Other data on file, last reported at $270000.0 in Q1 2025.

  • For the quarter ending Q1 2025, Receivables - Other changed N/A year-over-year to $270000.0; the trailing twelve-month figure through Mar 2025 stood at $270000.0 (changed N/A YoY), and the FY2024 full-year result was $950000.0, changed N/A from the prior year.
  • Receivables - Other for Q1 2025 stood at $270000.0, down from $950000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $36.3 million in Q1 2023 and bottomed at $270000.0 in Q1 2025.
  • The 5-year median for Receivables - Other is $16.8 million (2021), against an average of $16.4 million.
  • The widest annual swing landed in 2021, when Receivables - Other plunged 57.06%; it then jumped 177.55% in 2023.
  • A 5-year view of Receivables - Other shows it stood at $22.4 million in 2021, then declined by 4.69% to $21.3 million in 2022, then jumped by 70.14% to $36.3 million in 2023, then sank by 97.38% to $950000.0 in 2024, then plunged by 71.58% to $270000.0 in 2025.
  • The last three Receivables - Other figures came in at $270000.0 (Q1 2025), $950000.0 (Q4 2024), and $36.3 million (Q1 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 MeiraGTx Holdings 856.58 Mn 790.65 Mn 74.89 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 270,000.00
Mar 31, 2025 270,000.00
Dec 31, 2024 950,000.00
Dec 31, 2024 950,000.00
Mar 31, 2023 36.30 Mn
Mar 31, 2023 36.30 Mn
Dec 31, 2022 21.33 Mn
Dec 31, 2022 21.33 Mn
Sep 30, 2022 23.70 Mn
Sep 30, 2022 23.70 Mn
Jun 30, 2022 15.94 Mn
Jun 30, 2022 15.94 Mn
Mar 31, 2022 13.08 Mn
Mar 31, 2022 13.08 Mn
Dec 31, 2021 22.38 Mn
Dec 31, 2021 22.38 Mn
Sep 30, 2021 16.78 Mn
Sep 30, 2021 16.78 Mn
Jun 30, 2021 17.97 Mn
Jun 30, 2021 17.97 Mn
Mar 31, 2021 12.02 Mn
Mar 31, 2021 12.02 Mn
Dec 31, 2020 38.48 Mn
Dec 31, 2020 38.48 Mn
Sep 30, 2020 26.64 Mn
Sep 30, 2020 26.64 Mn
Jun 30, 2020 24.43 Mn
Jun 30, 2020 24.43 Mn
Mar 31, 2020 27.98 Mn
Mar 31, 2020 27.98 Mn
Dec 31, 2019 23.34 Mn
Dec 31, 2019 23.34 Mn